Publications
137
Citations
4,859
Est. group size
~1
Recurring co-author estimate
Active years
50
Publishing since 1977
Andrea Bonetto studies cancer cachexia, the severe muscle and body-weight loss that often accompanies cancer and its treatments. The work combines laboratory models (in mice and cells) with patient studies to understand how tumors and chemotherapy damage skeletal muscle and bone, and to test potential ways to prevent or slow this deterioration. Recent projects focus on cachexia in ovarian and head-and-neck cancers and on exercise and drug-based interventions.
Publication activity peaked around 2019–2022 and has been lower but steady in the years since, averaging about seven papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
No award with a current end date on record.
2 earlier awards
- NIH R01AR079379Jul 2021 – May 2026 · $442k awarded
Targeting RANKL for the treatment of muscle and bone defects in cachexia
- NIH R21CA190028Sep 2014 – Aug 2016 · $170k awarded
(PQB-3) Roles of skeletal muscle mass in chemotherapy-associated cachexia
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~6 · 14% small-team papers (≤3 authors) · across 22 venues
- Impact of sarcopenia and cachexia on patients with gynecologic malignancies in an oncologic exercise program
SSRN Electronic Journal · 2026
- Prevalence of ovarian cancer cachexia in patients undergoing cytoreductive surgery at the University of Colorado between 2014-2024
Journal of Ovarian Research · 2026
- Prevalence of ovarian cancer cachexia in patients undergoing cytoreductive surgery at the University of Colorado between 2014–2024
Gynecologic Oncology · 2026
- Effect of chemotherapy on skeletal muscle in in-vitro and vivo models
Gynecologic Oncology · 2026
- MOTS-c partially protects against skeletal muscle deterioration in C26 cachexia
Frontiers in Medicine · 2026
- B0092 tumor-bearing mice are a new model for the study of cachexia in head and neck cancer
American Journal of Physiology-Cell Physiology · 2025
- Vincristine impairs musculoskeletal development in pediatric mice
BMC Cancer · 2025
- Feasibility and impact of an exercise program on cancer cachexia in patients with gynecologic primary malignancies
Gynecologic Oncology · 2025
- Prevalence of ovarian cancer cachexia in patients undergoing debulking surgery at the University of Colorado between 2014–2024
Gynecologic Oncology Reports · 2025
- Masseter muscle thickness is predictive of cancer cachexia in patients with head and neck cancer
Head & Neck · 2024
- Diversity in chemotherapy-induced cachexia
American Journal of Physiology-Cell Physiology · 2024
- Mechanisms of Ovarian Cancer-Associated Cachexia
Endocrinology · 2023
- Postoperative consequences of cancer cachexia after head and neck free flap reconstruction
Head & Neck · 2022
- Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments
Cells · 2021
- Sarcopenia is associated with blood transfusions in head and neck cancer free flap surgery
Laryngoscope Investigative Otolaryngology · 2021
- PMC×9
- Journal of Cachexia Sarcopenia and Muscle×5
- The FASEB Journal×4
- Cancers×4
- Publisher×4
- Ernie D. Au
Medicine · Indiana University
- Teresa A. Zimmers
Medicine · Indiana University
- Ashok Narasimhan
Medicine · Indiana University
- Marion E. Couch
Medicine · Indiana University
- Priyani Rajasekera
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile